{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:47:12Z","timestamp":1791254832705,"version":"4.1.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) is a major threat to global health. By 2050, it is forecast that AMR will cause 10 million deaths and cost 100 trillion USD annually. Point-of-care tests (POCTs) may represent a cost-effective approach to reduce AMR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We systematically reviewed which POCTs addressing AMR have undergone economic evaluation in primary and secondary healthcare globally, how these POCTs have been economically evaluated, and which are cost-effective in reducing antimicrobial prescribing or the burden of AMR. Clinical cost-effectiveness was additionally addressed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This systematic review, accordant with PRISMA guidelines, was pre-registered on PROSPERO (CRD42022315192). MEDLINE, PubMed, Embase, Cochrane Library, and Google Scholar were searched from 2000 to 2023 for relevant publications. Quality assessment was performed using the Consensus of Health Economic Criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The search strategy identified 1421 studies, of which 20 met the inclusion criteria. The most common POCTs assessed were for respiratory infections (n\u200a=\u200a10), STIs (n\u200a=\u200a3), and febrile patients in low- and middle-income countries (n\u200a=\u200a3). All studies assessed costs from a healthcare provider perspective; five additionally considered the societal cost of AMR.<\/jats:p>\n                  <jats:p>Eighteen studies identified POCT strategies that reduced antimicrobial prescribing. Of these, 10 identified POCTs that would be considered cost-effective at a willingness-to-pay (WTP) threshold of \u00a333.80 per antibiotic prescription avoided. Most POCT strategies improved clinical outcomes (n\u200a=\u200a14); the remainder were clinically neutral.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>There is evidence that some POCTs are cost-effective in reducing antimicrobial prescribing, with potential concomitant clinical benefits. Such interventions\u2014especially CRP POCTs in both high- and low-income settings\u2014merit further, large-scale clinical evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae067","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T22:05:13Z","timestamp":1710799513000},"page":"1248-1269","source":"Crossref","is-referenced-by-count":30,"title":["Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-4575","authenticated-orcid":false,"given":"Abraham","family":"Tolley","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Bansal","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of Sydney , Sydney , Australia"},{"name":"Department of Internal Medicine, St Vincent\u2019s Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Murerwa","sequence":"additional","affiliation":[{"name":"Chuka County Referral Hospital , Chuka , Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5602-0366","authenticated-orcid":false,"given":"James","family":"Howard Dicks","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2024060223520154200_dkae067-B1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"2024060223520154200_dkae067-B2","doi-asserted-by":"crossref","first-page":"e002104","DOI":"10.1136\/bmjgh-2019-002104","article-title":"Tackling antimicrobial resistance in low-income and middle-income countries","volume":"4","author":"Pokharel","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2024060223520154200_dkae067-B3","author":"WHO"},{"key":"2024060223520154200_dkae067-B4","author":"O\u2019Neill"},{"key":"2024060223520154200_dkae067-B5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"2024060223520154200_dkae067-B6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/antibiotics11101362","article-title":"Antimicrobial resistance and its drivers\u2014a review","volume":"11","author":"Irfan","year":"2022","journal-title":"Antibiotics"},{"key":"2024060223520154200_dkae067-B7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2296-14-120","article-title":"Visit complexity, diagnostic uncertainty, and antibiotic prescribing for acute cough in primary care: a retrospective study","volume":"14","author":"Whaley","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2024060223520154200_dkae067-B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41533-021-00229-9","article-title":"Does diagnostic uncertainty increase antibiotic prescribing in primary care?","volume":"31","author":"Wang","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"2024060223520154200_dkae067-B9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jpids\/piw016","article-title":"Challenges in the etiology and diagnosis of acute febrile illness in children in low- and middle-income countries","volume":"5","author":"Tam P-Y","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2024060223520154200_dkae067-B10","author":"WHO"},{"key":"2024060223520154200_dkae067-B11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.322.7297.1285","article-title":"Regular review: point of care testing","volume":"322","author":"Price","year":"2001","journal-title":"BMJ"},{"key":"2024060223520154200_dkae067-B12","doi-asserted-by":"crossref","first-page":"e003622","DOI":"10.1136\/bmjgh-2020-003622","article-title":"Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings","volume":"5","author":"Okeke","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2024060223520154200_dkae067-B13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2753.2010.01472.x","article-title":"C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial","volume":"17","author":"Cals","year":"2011","journal-title":"J Eval Clin Pract"},{"key":"2024060223520154200_dkae067-B14","doi-asserted-by":"crossref","first-page":"e000086","DOI":"10.1136\/bmjresp-2015-000086","article-title":"Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI)","volume":"2","author":"Cooke","year":"2015","journal-title":"BMJ Open Respir Res"},{"key":"2024060223520154200_dkae067-B15","doi-asserted-by":"crossref","first-page":"15076","DOI":"10.1038\/npjpcrm.2015.76","article-title":"C-reactive protein point-of-care testing and antibiotic prescribing for acute respiratory tract infections in rural primary health centres of north Ethiopia: a cross-sectional study","volume":"26","author":"Yebyo","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"key":"2024060223520154200_dkae067-B16","doi-asserted-by":"crossref","first-page":"e025036","DOI":"10.1136\/bmjopen-2018-025036","article-title":"Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis","volume":"9","author":"Verbakel","year":"2019","journal-title":"BMJ Open"},{"key":"2024060223520154200_dkae067-B17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/antibiotics9090610","article-title":"Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2020","journal-title":"Antibiotics"},{"key":"2024060223520154200_dkae067-B18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s41669-020-00248-1","article-title":"Health economic evidence of point-of-care testing: a systematic review","volume":"5","author":"Lingervelder","year":"2021","journal-title":"Pharmacoecon Open"},{"key":"2024060223520154200_dkae067-B19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/hec.693","article-title":"Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?","volume":"11","author":"Coast","year":"2002","journal-title":"Health Econ"},{"key":"2024060223520154200_dkae067-B20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1099-1050(199605)5:3<217::AID-HEC200>3.0.CO;2-S","article-title":"Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?","volume":"5","author":"Coast","year":"1996","journal-title":"Health Econ"},{"key":"2024060223520154200_dkae067-B21","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/AAC.00825-16","article-title":"Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs","volume":"60","author":"Karanika","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024060223520154200_dkae067-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024060223520154200_dkae067-B23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhin.2019.03.002","article-title":"The economic impact of antimicrobial stewardship programmes in hospitals: a systematic literature review","volume":"102","author":"Huebner","year":"2019","journal-title":"J Hosp Infect"},{"key":"2024060223520154200_dkae067-B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13756-023-01265-5","article-title":"A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance","volume":"12","author":"Painter","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024060223520154200_dkae067-B25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/1355819021927764","article-title":"Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness","volume":"7","author":"Wilton","year":"2002","journal-title":"J Health Serv Res Policy"},{"key":"2024060223520154200_dkae067-B26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jac\/dkad021","article-title":"Cost-effectiveness of point-of-care interventions to tackle inappropriate prescribing of antibiotics in high- and middle-income countries: a systematic review","volume":"78","author":"D\u2019hulster","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2024060223520154200_dkae067-B27","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/jac\/dkac185","article-title":"Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment","volume":"77","author":"Wubishet","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024060223520154200_dkae067-B28","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024060223520154200_dkae067-B29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jclinepi.2020.01.008","article-title":"A full systematic review was completed in 2\u2005weeks using automation tools: a case study","volume":"121","author":"Clark","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"2024060223520154200_dkae067-B30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"2024060223520154200_dkae067-B31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/fampra\/cmab123","article-title":"A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model","volume":"39","author":"Fawsitt","year":"2022","journal-title":"Fam Pract"},{"key":"2024060223520154200_dkae067-B32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/antibiotics7040106","article-title":"Cost-effectiveness analysis of the use of point-of-care C-reactive protein testing to reduce antibiotic prescribing in primary care","volume":"7","author":"Holmes","year":"2018","journal-title":"Antibiotics"},{"key":"2024060223520154200_dkae067-B33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12325-015-0180-x","article-title":"Cost-Effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England","volume":"32","author":"Hunter","year":"2015","journal-title":"Adv Ther"},{"key":"2024060223520154200_dkae067-B34","doi-asserted-by":"crossref","first-page":"e055234","DOI":"10.1136\/bmjopen-2021-055234","article-title":"Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial","volume":"12","author":"Boere","year":"2022","journal-title":"BMJ Open"},{"key":"2024060223520154200_dkae067-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24150","article-title":"C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT","volume":"24","author":"Francis","year":"2020","journal-title":"Health Technol Assess"},{"key":"2024060223520154200_dkae067-B36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13756-018-0414-1","article-title":"C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting\u2014a cost benefit analysis","volume":"7","author":"Lubell","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024060223520154200_dkae067-B37","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.3399\/bjgp13X669185","article-title":"Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions","volume":"63","author":"Oppong","year":"2013","journal-title":"Br J Gen Pract"},{"key":"2024060223520154200_dkae067-B38","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1093\/jac\/dky309","article-title":"Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe","volume":"73","author":"Oppong","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024060223520154200_dkae067-B39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11606-013-2679-7","article-title":"Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults","volume":"29","author":"Michaelidis","year":"2014","journal-title":"J Gen Intern Med"},{"key":"2024060223520154200_dkae067-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18060","article-title":"PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study","volume":"18","author":"Little","year":"2014","journal-title":"Health Technol Assess"},{"key":"2024060223520154200_dkae067-B41","doi-asserted-by":"crossref","first-page":"1900402","DOI":"10.2807\/1560-7917.ES.2020.25.43.1900402","article-title":"Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics","volume":"25","author":"Harding-Esch","year":"2020","journal-title":"Euro Surveill"},{"key":"2024060223520154200_dkae067-B42","doi-asserted-by":"crossref","first-page":"e015447","DOI":"10.1136\/bmjopen-2016-015447","article-title":"Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study","volume":"7","author":"Turner","year":"2017","journal-title":"BMJ Open"},{"key":"2024060223520154200_dkae067-B43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/sextrans-2013-051147","article-title":"An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England","volume":"90","author":"Turner","year":"2014","journal-title":"Sex Transm Infect"},{"key":"2024060223520154200_dkae067-B44","doi-asserted-by":"crossref","first-page":"e0258299","DOI":"10.1371\/journal.pone.0258299","article-title":"Cost-effectiveness of point-of-care C-reactive protein test compared to current clinical practice as an intervention to improve antibiotic prescription in malaria-negative patients in Afghanistan","volume":"16","author":"Dickinson","year":"2021","journal-title":"PLoS One"},{"key":"2024060223520154200_dkae067-B45","doi-asserted-by":"crossref","first-page":"e0227409","DOI":"10.1371\/journal.pone.0227409","article-title":"When and what to test for: a cost-effectiveness analysis of febrile illness test-and-treat strategies in the era of responsible antibiotic use","volume":"15","author":"Zhang","year":"2020","journal-title":"PLoS One"},{"key":"2024060223520154200_dkae067-B46","doi-asserted-by":"crossref","first-page":"e0152420","DOI":"10.1371\/journal.pone.0152420","article-title":"Modelling the impact and cost-effectiveness of biomarker tests as compared with pathogen-specific diagnostics in the management of undifferentiated fever in remote tropical settings","volume":"11","author":"Lubell","year":"2016","journal-title":"PLoS One"},{"key":"2024060223520154200_dkae067-B47","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1038\/s41598-019-47359-2","article-title":"Modeling and cost benefit analysis to guide deployment of POC diagnostics for non-typhoidal Salmonella infections with antimicrobial resistance","volume":"9","author":"Manore","year":"2019","journal-title":"Sci Rep"},{"key":"2024060223520154200_dkae067-B48","first-page":"1","article-title":"A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT","volume":"26","author":"Daniels","year":"2022","journal-title":"Health Technol Assess"},{"key":"2024060223520154200_dkae067-B49","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.3399\/bjgp18X695285","article-title":"Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness","volume":"68","author":"Butler","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2024060223520154200_dkae067-B50","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.168.18.2000","article-title":"Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care","volume":"168","author":"Briel","year":"2008","journal-title":"Arch Intern Med"},{"key":"2024060223520154200_dkae067-B51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.00163309","article-title":"Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection","volume":"36","author":"Burkhardt","year":"2010","journal-title":"Eur Respir J"},{"key":"2024060223520154200_dkae067-B52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13756-018-0384-3","article-title":"Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use","volume":"7","author":"Shrestha","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024060223520154200_dkae067-B53","doi-asserted-by":"crossref","first-page":"e0000710","DOI":"10.1371\/journal.pgph.0000710","article-title":"Diagnostic tests to mitigate the antimicrobial resistance pandemic\u2014still the problem child","volume":"2","author":"Ferreyra","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"2024060223520154200_dkae067-B54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/fampra\/cmr031","article-title":"A multi-country qualitative study of clinicians\u2019 and patients\u2019 views on point of care tests for lower respiratory tract infection","volume":"28","author":"Wood","year":"2011","journal-title":"Fam Pract"},{"key":"2024060223520154200_dkae067-B55","doi-asserted-by":"crossref","first-page":"1900408","DOI":"10.2807\/1560-7917.ES.2020.25.44.1900408","article-title":"Effects of primary care C-reactive protein point-of-care testing on antibiotic prescribing by general practice staff: pragmatic randomised controlled trial, England, 2016 and 2017","volume":"25","author":"Eley","year":"2020","journal-title":"Euro Surveill"},{"key":"2024060223520154200_dkae067-B56","author":"NICE"},{"key":"2024060223520154200_dkae067-B57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10198-010-0239-1","article-title":"Resource use and costs of treating acute cough\/lower respiratory tract infections in 13 European countries: results and challenges","volume":"12","author":"Oppong","year":"2011","journal-title":"Eur J Health Econ"},{"key":"2024060223520154200_dkae067-B58","doi-asserted-by":"crossref","first-page":"e005611","DOI":"10.1136\/bmjopen-2014-005611","article-title":"Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA","volume":"4","author":"Howick","year":"2014","journal-title":"BMJ Open"},{"key":"2024060223520154200_dkae067-B59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024060223520154200_dkae067-B60","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","volume":"70","author":"Kamat","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024060223520154200_dkae067-B61","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12890-021-01672-7","article-title":"C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections","volume":"21","author":"Duan","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2024060223520154200_dkae067-B62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13054-018-2236-1","article-title":"The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review","volume":"22","author":"Ruan","year":"2018","journal-title":"Crit Care"},{"key":"2024060223520154200_dkae067-B63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/sextrans-2013-051500","article-title":"Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam","volume":"90","author":"Bartelsman","year":"2014","journal-title":"Sex Transm Infect"},{"key":"2024060223520154200_dkae067-B64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/sextrans-2011-050355","article-title":"Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting","volume":"89","author":"Huang","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2024060223520154200_dkae067-B65","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.5858\/arpa.2020-0118-RA","article-title":"Point-of-care testing for sexually transmitted infections: a review of recent developments","volume":"144","author":"Adamson","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"2024060223520154200_dkae067-B66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-017-0881-x","article-title":"Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study","volume":"15","author":"Fingerhuth","year":"2017","journal-title":"BMC Med"},{"key":"2024060223520154200_dkae067-B67","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix450","article-title":"Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea","volume":"216","author":"Tuite","year":"2017","journal-title":"J Infect Dis"},{"key":"2024060223520154200_dkae067-B68","first-page":"1268","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system","volume":"64","author":"Allan-Blitz","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024060223520154200_dkae067-B69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024060223520154200_dkae067-B70","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/ciac371","article-title":"Resistance-guided therapy for Neisseria gonorrhoeae","volume":"75","author":"Allan-Blitz","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024060223520154200_dkae067-B71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cid\/ciaa591","article-title":"Antimicrobial resistance in gonorrhea: diagnostics to the rescue","volume":"73","author":"Marks","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024060223520154200_dkae067-B72","doi-asserted-by":"crossref","first-page":"e25343","DOI":"10.1002\/jia2.25343","article-title":"Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward","volume":"22","author":"Wi","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2024060223520154200_dkae067-B73","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1371\/journal.pntd.0000610","article-title":"Strategies for diagnosis and treatment of suspected leptospirosis: a cost-benefit analysis","volume":"4","author":"Suputtamongkol","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/6\/1248\/58036485\/dkae067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/6\/1248\/58036485\/dkae067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:53:23Z","timestamp":1717372403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/6\/1248\/7631242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae067","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,18]]}}}